Jeffrey W. Albers
2019
In 2019, Jeffrey W. Albers earned a total compensation of $9.4M as President and Chief Executive Officer at Blueprint Medicines, a 4% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $378,780 |
|---|---|
| Option Awards | $5,808,841 |
| Salary | $590,000 |
| Stock Awards | $2,576,350 |
| Other | $8,400 |
| Total | $9,362,371 |
Albers received $5.8M in option awards, accounting for 62% of the total pay in 2019.
Albers also received $378.8K in non-equity incentive plan, $590K in salary, $2.6M in stock awards and $8.4K in other compensation.
Rankings
In 2019, Jeffrey W. Albers' compensation ranked 841st out of 13,971 executives tracked by ExecPay. In other words, Albers earned more than 94.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 841 out of 13,971 | 94th |
Division Manufacturing | 293 out of 5,701 | 95th |
Major group Chemicals And Allied Products | 84 out of 2,200 | 96th |
Industry group Drugs | 68 out of 1,886 | 96th |
Industry Pharmaceutical Preparations | 55 out of 1,398 | 96th |
Pay ratio
| Jeffrey W. Albers' Pay | $9,362,371 |
|---|---|
| Median Employee's Pay | $360,897 |
| Pay Ratio | 26to 1 |
In 2019, the annual total compensation of Jeffrey W. Albers was $9,362,371.
The annual total compensation of the median employee at Blueprint Medicines was $360,897.
The ratio of Jeffrey W. Albers' pay to the pay of median employee was therefore 26 to one.
Source: SEC filing on April 29, 2020.
Albers' colleagues
We found four more compensation records of executives who worked with Jeffrey W. Albers at Blueprint Medicines in 2019.